Transcript
Page 1: Transcranial Magnetic Stimulation (TMS) in Clinical and

Transcranial Magnetic Stimulation (TMS) in Clinical and Experimental

Epilepsy

Alexander Rotenberg, M.D., Ph.D. Dept. Neurology

Children’s Hospital, Boston

Page 2: Transcranial Magnetic Stimulation (TMS) in Clinical and

Nexstim Inc.

TMS Basics

Frye, Rotenberg et al., 2007

• Focal, noninvasive cortical stimulation • Two FDA-approved devices:

• presurgical motor mapping • treatment of major depression

Neuronetics Inc.

Page 3: Transcranial Magnetic Stimulation (TMS) in Clinical and

TMS in Presurgical* Motor ** Mapping Motor

Perilesional mapping (Najib et al., 2011)

Lesional and contra-lesional mapping (Rotenberg, unpublished)

*Particularly for patients who do not tolerate Wada or fMRI **TMS for language mapping: likely soon

R hand L hand

Page 4: Transcranial Magnetic Stimulation (TMS) in Clinical and

Antiepileptic rTMS

- Numerous open label trials; three RCT - Most effective if over superficial neocortical focus - 1 Hz rTMS more effective than other low frequencies

Theodore et al., 2003 (11)

Cantello et al., 2007 (43)

Fregni et al., 2006 (9)

Theodore et al., 2003 (6)

Cantello et al., 2007 (43)

Fregni et al., 2006 (3)

Theodore et al., 2003 (6)

Fregni et al., 2006 (9)

Change  in  Seizure  Frequency  (%)  a4er  0.3-­‐1  Hz  rTMS  

Target rTMS

Placebo rTMS

2.0 -­‐71.6   --6.0

(modified from Bae et al., Epilepsy Behav 2011)

Nontarget rTMS

Deep TMS H-Coil System

Epilepsy Therapy Project Award: Controlled trial of 1 Hz rTMS for treatment of temporal lobe epilepsy

Page 5: Transcranial Magnetic Stimulation (TMS) in Clinical and

1

Conditioning TMS

2 Test TMS

Control

SICI; 2 ms ISI

ICF; 12 ms ISI 0.5 mV

25 ms

LICI; 200 ms ISI

0.5 mV

50 ms Rotenberg and Pascual-Leone, 2010

Measures of Cortical Excitability by Paired-Pulse TMS (ppTMS)

ISI

Page 6: Transcranial Magnetic Stimulation (TMS) in Clinical and

Brodtmann et al., Neurology 1999

TMS Biomarkers in Epilepsy

Loss of inhibition in epilepsy

Di Lazzarro et al., Neurology 2004

Enhanced inhibition with VNS

Drug Mode MT MEP SICI ICF

CBZ Na+ + = - -

LTG Na+ +++ - = =

PHT Na+ ++ - = =

LZP GABA = - ++ -

DZP GABA = - + -

TMS and drugs

Zieman, Clin Neurophys 2004

Cantello et al., Epilepsia 2007;

Enhanced inhibition in keto diet

Page 7: Transcranial Magnetic Stimulation (TMS) in Clinical and

Future directions: THANKS!

CHB –  Frances Jensen –  Blaise Bourgeois –  Ann Marie Bergin –  Tobias Loddenkemper –  Masanori Takeoka –  Andrew Vahabzadeh –  Tsung-Hsun Hsien –  Sameer Dhame –  Paul Muller –  Mustafa Hameed –  Grant Goodrich –  Lindsay Oberman –  Roman Gersner –  Guangpin Zhang

BIDMC / Spaulding –  Alvaro Pascual-Leone –  Donald Schomer –  Felipe Fregni –  Steve Schachter

SUPPORT –  Epilepsy Research

Foundation –  CIMIT –  CURE –  Department of Defense –  NIH NINDS –  Siegal and al Rashedi

families –  Brainsway Inc. –  Nexstim Inc.

Translational TMS: Measures of cortical inhibition in post-traumatic epileptogenesis

Normal rat

TBI rat

LICI

Weeks after TBIPre 1WK 2WKS 3WKS 4WKS 5WKS 6WKS

Rat

io

0.0

0.2

0.4

0.6

0.8

1.0Sham control ratsTBI rats

*** *

*

Hsieh et al., 2011

ppTMS in ketogenic diet: Does increase in cortical inhibition predict diet success?

rTMS in status epilepticus: Can rTMS suppress ongoing focal seizures?

TMS for preoperative language and motor mapping: Can rTMS supplement (or replace) Wada for some patients?

Page 8: Transcranial Magnetic Stimulation (TMS) in Clinical and

Language mapping


Top Related